In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.

MLA

Takashita, Emi, et al. “In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.” The New England Journal of Medicine, vol. 387, no. 22, Dec. 2022, pp. 2094–97. EBSCOhost, https://doi.org/10.1056/NEJMc2211845.

APA

Takashita, E., Yamayoshi, S., Halfmann, P., Wilson, N., Ries, H., Richardson, A., Bobholz, M., Vuyk, W., Maddox, R., Baker, D. A., Friedrich, T. C., O’Connor, D. H., Uraki, R., Ito, M., Sakai-Tagawa, Y., Adachi, E., Saito, M., Koga, M., Tsutsumi, T., … Kawaoka, Y. (2022). In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6. The New England Journal of Medicine, 387(22), 2094–2097. https://doi.org/10.1056/NEJMc2211845

Chicago

Takashita, Emi, Seiya Yamayoshi, Peter Halfmann, Nancy Wilson, Hunter Ries, Alex Richardson, Max Bobholz, et al. 2022. “In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.” The New England Journal of Medicine 387 (22): 2094–97. doi:10.1056/NEJMc2211845.